ArticleCureus2025
Prevalence of Eosinophilic Esophagitis in Patients With Gastroesophageal Reflux Symptoms.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEosinophilic esophagitis (EoE) is a chronic, immune- or antigen-mediated inflammatory condition of the esophagus, which is characterized by eosinophil-predominant infiltration and resulting esophageal dysfunction. In adults, it typically presents with dysphagia and food impaction. In children, common symptoms include vomiting, feeding difficulties, and abdominal pain. Diagnosis is established in symptomatic individuals by esophagogastroduodenoscopy with esophageal biopsy, demonstrating at least 15 eosinophils per high-power field (HPF) in the esophageal mucosa. Despite increasing recognition of EoE globally, data from low- and middle-income countries (LMICs), including Nepal, remain scarce.
objectivesThis study was conducted to find the prevalence of EoE in patients with symptoms of gastroesophageal reflux (GER) in Nepal. MATERIALS AND
methodsA cross-sectional study was carried out at the tertiary care level central hospital in Nepal from January 2024 to August 2024, among a total of 60 participants with symptoms of GER. All participants underwent an esophagogastroduodenoscopy (EGD), and esophageal biopsies were taken to check for the presence of eosinophilic esophagitis (EoE). Data on demographic and clinical characteristics, endoscopic findings, peripheral blood absolute eosinophil count, and history of proton pump inhibitors (PPI) use were obtained. Statistical analysis was done using IBM SPSS Statistics for Windows, version 21 (IBM Corp., Armonk, NY, USA).
resultsEoE was identified in four patients (6.67%) based on histopathological examination of esophageal biopsy samples with no gender predilection and was found predominantly in participants aged 40 or more. The findings suggest the consideration of EoE as a diagnostic possibility in patients with GER symptoms in Nepal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.